{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:02:02Z","timestamp":1774558922580,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.clinthera.2015.03.010","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T09:11:39Z","timestamp":1428570699000},"page":"1206-1215","source":"Crossref","is-referenced-by-count":22,"title":["Association Between Colchicine and Risk of Diabetes Among the Veterans Affairs Population With Gout"],"prefix":"10.1016","volume":"37","author":[{"given":"Liya","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingnan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gandahari Rosa","family":"Carpio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2015.03.010_bib1","first-page":"S435","article-title":"Epidemiology of hyperuricemia and gout","volume":"11","author":"Luk","year":"2005","journal-title":"Am J Managed Care"},{"key":"10.1016\/j.clinthera.2015.03.010_bib2","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2015.03.010_bib3","first-page":"353","article-title":"Medical implications of hyperuricemia","volume":"92","author":"Sachs","year":"2009","journal-title":"Med Health R I"},{"key":"10.1016\/j.clinthera.2015.03.010_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/BOR.0b013e3283257b96","article-title":"The role of hyperuricemia in vascular disorders","volume":"21","author":"Edwards","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clinthera.2015.03.010_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.1780310618","article-title":"Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout","volume":"31","author":"Axelrod","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2015.03.010_bib6","first-page":"199","article-title":"Gout and its comorbidities","volume":"68","author":"Pillinger","year":"2010","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.clinthera.2015.03.010_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2474-12-103","article-title":"Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population","volume":"12","author":"Primatesta","year":"2011","journal-title":"BMC Musculoskel Disord"},{"key":"10.1016\/j.clinthera.2015.03.010_bib8","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/rheumatology\/ken305","article-title":"Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile","volume":"47","author":"Choi","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2015.03.010_bib9","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2015.03.010_bib10","first-page":"CD006190","article-title":"Colchicine for acute gout","author":"Schlesinger","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2015.03.010_bib11","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Gout","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2015.03.010_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11926-002-0073-2","article-title":"Update on colchicine and its mechanism of action","volume":"4","author":"Molad","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clinthera.2015.03.010_bib13","first-page":"213","article-title":"Colchicine in diabetes mellitus","volume":"41","author":"Das","year":"1993","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.clinthera.2015.03.010_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/sj.pcan.4500889","article-title":"The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting","volume":"9","author":"Kastner","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clinthera.2015.03.010_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.clinthera.2015.03.010_bib16","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/eurheartj\/ehr031","article-title":"An overview of the objectives of and the approaches to propensity score analyses","volume":"32","author":"Heinze","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2015.03.010_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1467-6419.2007.00527.x","article-title":"Some practical guidance for the implementation of propensity score matching","volume":"22","author":"Caliendo","year":"2008","journal-title":"J Econ Surv"},{"key":"10.1016\/j.clinthera.2015.03.010_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.298.2.187","article-title":"Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis","volume":"298","author":"Wasko","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2015.03.010_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2288-10-20","article-title":"Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer","volume":"10","author":"Bellera","year":"2010","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.clinthera.2015.03.010_bib20","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2015.03.010_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2337\/dc11-1588","article-title":"Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies","volume":"35","author":"Kengne","year":"2012","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/j.clinthera.2015.03.010_bib22","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1089\/dia.2012.0106","article-title":"Current knowledge and future directions on cardiovascular disease in diabetes","volume":"14","author":"Maahs","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.clinthera.2015.03.010_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(86)90451-1","article-title":"Asymptomatic myocardial ischemia in diabetic patients","volume":"80","author":"Nesto","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2015.03.010_bib24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3949\/ccjm.78a.10180","article-title":"Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them","volume":"78","author":"Lansang","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.clinthera.2015.03.010_bib25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1525-1497.2002.10649.x","article-title":"Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly","volume":"17","author":"Blackburn","year":"2002","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.clinthera.2015.03.010_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/dmrr.2486","article-title":"Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment","volume":"30","author":"Hwang","year":"2014","journal-title":"Diabetes\/Metab Res Rev"},{"key":"10.1016\/j.clinthera.2015.03.010_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1631\/jzus.2007.B0593","article-title":"Relationship between hyperuricemia and metabolic syndrome","volume":"8","author":"Chen","year":"2007","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.clinthera.2015.03.010_bib28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjmed.2010.03.027","article-title":"Serum uric acid levels and the risk of type 2 diabetes: a prospective study","volume":"123","author":"Bhole","year":"2010","journal-title":"Am J Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815001472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815001472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T05:11:59Z","timestamp":1566537119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291815001472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0149291815001472"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2015.03.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}